High-dose steroids do not improve early outcome in biliary atresia

Journal of Pediatric Surgery

Volumn 42, Issue 12, 2007, Pages 2102-2105

  Vejchapipat, Paisarn ^a   Passakonnirin, Rojjana ^a   Sookpotarom, Paiboon ^a   Chittmittrapap, Soottiporn ^a   Poovorawan, Yong ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Biliary atresia; Jaundice; Steroids

Indexed keywords

ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; COTRIMOXAZOLE; PREDNISOLONE; RETINOL; STEROID; URSODEOXYCHOLIC ACID; VITAMIN D; VITAMIN K GROUP;

ARTICLE; BILE DUCT ATRESIA; CHOLANGITIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HUMAN; INFANT; JAUNDICE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME;

BILIARY ATRESIA; BILIARY TRACT SURGICAL PROCEDURES; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; POSTOPERATIVE CARE; PREDNISOLONE; PROBABILITY; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 36849017887     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2007.08.038     Document Type: Article

References (28)

1. Ohi R. Surgery for biliary atresia. Liver 21 (2001) 175-182
2. Utterson E.C., Shepherd R.W., Sokol R.J., et al. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr 147 (2005) 180-185
3. Davenport M. Biliary atresia. Semin Pediatr Surg 14 (2005) 42-48
4. Petersen C., and Ure B.M. What's new in biliary atresia?. Eur J Pediatr Surg 13 (2003) 1-6
5. Haber B.A., and Russo P. Biliary atresia. Gastroenterol Clin North Am 32 (2003) 891-911
6. Bezerra J.A. Biliary atresia-translational research on key molecular processes regulating biliary injury and obstruction. Chang Gung Med J 29 (2006) 222-230
7. Vejchapipat P., Jirapanakorn N., Thawornsuk N., et al. There is no association between K469E ICAM-1 gene polymorphism and biliary atresia. World J Gastroenterol 11 (2005) 4886-4890
8. Kobayashi H., and Stringer M.D. Biliary atresia. Semin Neonatol 8 (2003) 383-391
9. Karrer F.M., and Lilly J.R. Corticosteroid therapy in biliary atresia. J Pediatr Surg 20 (1985) 693-695
10. Muraji T., Nishijima E., Higashimoto Y., et al. Biliary atresia: current management and outcome. Tohoku J Exp Med 181 (1997) 155-160
11. Meyers R.L., Book L.S., O'Gorman M.A., et al. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg 38 (2003) 406-411
12. Escobar M.A., Jay C.L., Brooks R.M., et al. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg 41 (2006) 99-103
13. Tatekawa Y., Muraji T., and Tsugawa C. Glucocorticoid receptor alpha expression in the intrahepatic biliary epithelium and adjuvant steroid therapy in infants with biliary atresia. J Pediatr Surg 40 (2005) 1574-1580
14. Kobayashi H., Yamataka A., Koga H., et al. Optimum prednisolone usage in patients with biliary atresia postportoenterostomy. J Pediatr Surg 40 (2005) 327-330
15. Muraji T., Nio M., Ohhama Y., et al. Postoperative corticosteroid therapy for bile drainage in biliary atresia-a nationwide survey. J Pediatr Surg 39 (2004) 1803-1805
16. Nio M., and Ohi R. Biliary atresia. Semin Pediatr Surg 9 (2000) 177-186
17. Nittono H., Tokita A., Hayashi M., et al. Ursodeoxycholic acid therapy in the treatment of biliary atresia. Biomed Pharmacother 43 (1989) 37-41
18. Ullrich D., Rating D., Schroter W., et al. Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation. Lancet 2 (1987) 1324
19. Chuang J.H., Chou M.H., Wu C.L., et al. Implication of innate immunity in the pathogenesis of biliary atresia. Chang Gung Med J 29 (2006) 240-250
20. Ohya T., Fujimoto T., Shimomura H., et al. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J Pediatr Surg 30 (1995) 515-518
21. Petersen C. Pathogenesis and treatment opportunities for biliary atresia. Clin Liver Dis 10 (2006) 73-88
22. Vejchapipat P., Chongsrisawat V., Theamboonlers A., et al. Elevated serum nitric oxide metabolites in biliary atresia. Pediatr Surg Int 22 (2006) 106-109
23. Honsawek S., Chongsrisawat V., Vejchapipat P., et al. Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters. Pediatr Surg Int 21 (2005) 73-77
24. Kobayashi H., Tamatani T., Tamura T., et al. The role of monocyte chemoattractant protein-1 in biliary atresia. J Pediatr Surg 41 (2006) 1967-1972
25. Altman R.P., and Anderson K.D. Surgical management of intractable cholangitis following successful Kasai procedure. J Pediatr Surg 17 (1982) 894-900
26. Hsieh C.S., Huang C.C., Huang L.T., et al. Glucocorticoid treatment down-regulates chemokine expression of bacterial cholangitis in cholestatic rats. J Pediatr Surg 39 (2004) 10-15
27. Dillon P.W., Owings E., Cilley R., et al. Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg 36 (2001) 80-85
28. Muraji T., and Higashimoto Y. The improved outlook for biliary atresia with corticosteroid therapy. J Pediatr Surg 32 (1997) 1103-1106